Challenges to Fda's Ability to Monitor and Inspect Foreign Clinical Trials

Creator

Unknown author

Bibliographic Citation

Washington, DC: U.S. Department of Health and Human Services, Office of Inspector General, 2010. 44 p. [Online]. Accessed: http://oig.hhs.gov/oei/reports/oei-01-08-00510.pdf [16 June 2011]

Permanent Link

Find in a Library
http://timetravel.mementoweb.org/memento/2010/http://oig.hhs.gov/oei/reports/oei-01-08-00510.pdf
http://hdl.handle.net/10822/1025374

Date

2010

Subject

Clinical Trials; Drugs and Drug Industry; Human Experimentation Policy Guidelines / Institutional Review Boards; Social Control of Human Experimentation;

Publisher

United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections

Collections

EthxWeb: Literature in Bioethics

Metadata

Show full item record